Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genzyme
Pharma
Sanofi sues Sarepta over 2 gene therapy manufacturing patents
Sanofi has filed a complaint claiming that in producing Duchenne muscular dystrophy treatment Elevidys, Sarepta encroaches on two of its patents.
Kevin Dunleavy
Jul 30, 2024 5:21pm
Appeals court revives litigation centered on Sanofi's Fabrazyme
Feb 20, 2024 5:09pm
Europe endorses two Sanofi enzyme replacement therapies
Jun 28, 2022 11:21am
Sanofi's story gets a fresh chapter with 'eureka!' undertones
Feb 7, 2022 8:45am
Sanofi's late-onset Pompe prospect has scooped its green light
Aug 6, 2021 2:39pm
Ex-Genzyme CFO takes up exec chair role at delivery specialist
Jul 27, 2021 6:24am
